new/era/mabs
  • services
  • blog
selma - 
our groundbreaking technology
service

selma - our groundbreaking technology

Since decades selection of antibody producing hybridoma cells has been performed by limited dilution and numerous ELISA screenings in order to find suitable antibody-producing cells. These processes are very laborious,

selma + murine monoclonal antibodies
service

selma + murine monoclonal antibodies

We base our immunization strategy onto the most efficient danger signals to the mammalian immune system: viruses. By combining efficient surface-related epitopes with a viral particle system originated from the

selma + human monoclonal antibodies
service

selma + human monoclonal antibodies

With our in house developed in vitro immunisation process we are able to activate naive B lymphocytes antigen-specifically within 12 days and fuse them afterwards with our transgenic fusion cell

selma + camelid recombinant antibodies
service

selma + camelid recombinant antibodies

For some applications conventional antibodies might not be suitable due to their size or the size of the requested antigen. Therefore, we offer the generation of recombinant camelid heavy-chain only

transgenic cells
service

transgenic cells

Beside our customized antibody generation systems, we provide the genetic engineering of mammalian cells. Initially we optimize your sequence of interest with the help of bioinformatics tools e.g. Kozak

new/era/mabs © 2023